At a glance
ClinicalIndex Comparison RecordN/ACompleted· 17 enrolled
Drug / intervention
BreEStim 120 +1 moredevice
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
A Non-invasive Intervention (BreEStim) for Management of Phantom Limb Pain (PLP) After Limb Amputation
The University of Texas Health Science Center, Houston·interventional·Posted Feb 11, 2021·Updated Mar 20, 2025
In Brief
A clinical study evaluating BreEStim 120 and BreEStim 240 for Pain Management. Completed, enrolled 17 participants across 1 site.
Detailed Summary
The purpose of this study is to compare the effectiveness of innovative intervention of breathing controlled electrical stimulation (BreEStim) and conventional electrical stimulation (EStim) in management of neuropathic phantom limb pain in patients after limb amputation.
Study Details
Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsPain Management
CountriesUnited States
Timeline
N/ACompletedFinished
202120222023202420252026
First PostedFeb 2021
Enrollment StartApr 2021
Primary CompletionMay 2023
TodayJul 2026
First PostedFeb 11, 2021
Enrollment StartApr 2, 2021
Primary CompletionMay 19, 2023
TodayJul 2, 2026
Enrollment to primary: 2.1 yearsPosted 5.4 years ago
Interventions
BreEStim 120device
120 BreEStim stimuli will applied for about 10-15 minutes.
BreEStim 240device
240 BreEStim stimuli will applied for about 20-30 minutes.